Monday, May 23, 2022
Mitochondrial Health

DAVID SINCLAIR ”NMN vs NR” | Dr David Sinclair & Dr Rhonda Patrick Interview Clips

NAD+ is one of the most abundant molecules in the human body, second only to water. It is required for approximately 500 different enzymatic reactions from energy metabolism to cell survival, rising and falling depending on food intake, exercise, and the time of day. NAD+ levels steadily decline with age, resulting in altered metabolism and increased disease susceptibility. As NAD+ boosting molecules, both NMN & have displayed therapeutic potential in preventing ageing phenotypes and promoting healthspan.

David Sinclair is a professor in the Department of Genetics and co-director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School, where he and his colleagues study sirtuins—protein-modifying enzymes that respond to changing NAD+ levels and to caloric restriction—as well as chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration, cancer, and cellular reprogramming.

Dr David Sinclair has suggested that aging is a disease—and that we may soon have the tools to put it into remission—and he has called for greater international attention to the social, economic and political and benefits of a world in which billions of people can live much longer and much healthier lives.

Dr David Sinclair is the co-founder of several biotechnology companies (Life Biosciences, Sirtris, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others.
He is also co-founder and co-chief editor of the journal Aging. He is an inventor on 35 patents and has received more than 35 awards and honors. In 2014, he was on Time Magazine’s list of the “100 Most Influential People in the World,” and listed as Time’s Top 50 in healthcare in 2018.
DISCLAIMER: Please note that none of the information in this video constitutes health advice or should be substituted in lieu of professional guidance. The video content is purely for informational purposes.

#DavidSinclair #NMN #NR #RhondaPatrick #OliveOil #OleicAcid #Sirtuins #Fasting #Exercise #ReverseAging #NMN #NADIV #Longevity #Epigenetic #RestoreYouth #Reprogramming #DavidSinclair #DrSinclairLab #Lifespan #Healthspan #Younger #Resveratrol #NMN #antiaging #DrSinclair #NAD #longevity #Bioscience #Epigenome


Similar Posts

6 thoughts on “DAVID SINCLAIR ”NMN vs NR” | Dr David Sinclair & Dr Rhonda Patrick Interview Clips
  1. The most bioavailable form is liposomal. Multiple companies have liposomal products of NMN, NR, and NAD+. The dose used is lower because a vastly higher percentage is presumably getting into cells.

    But no one has any idea of what this will mean in terms of practical results on cellular functioning. Before these liposomal forms, bioavailability was so infinitesimally small that this was compensated for by taking larger doses.

    Sinclair has still barely acknowledged the issue of liposomal form. And no one else has yet studied it for NAD+ itself and NAD+ boosters. It could be a game-changer, although it also might bring up problems not seen with less bioavailable forms. No one knows.

Leave a Reply

Your email address will not be published.